Cite
HARVARD Citation
Peyrin-Biroulet, L. et al. (n.d.). A17 EFFICACY AND SAFETY OF FILGOTINIB AS MAINTENANCE THERAPY FOR PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: RESULTS FROM THE PHASE 2B/3 SELECTION STUDY. Journal of the Canadian Association of Gastroenterology. pp. 21-23. [Online].